DPHARM: Disruptive Innovations Agenda 2026 Page 2

Kenneth Getz, MBA, Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

Showing Events in 1 Track from 08:40am to 10:15am

Day Two – Morning General Session

8:40AM - 9:10AM

Disrupting Clinical Operating Models: Managing Resources to Deliver Quality, Efficiency and Speed

David Carruthers, VP, BioPharmaceuticals and Global Head of Clinical Operations, AstraZeneca

Bernhard Glombitza, PhD, VP, Clinical Customer Engagement and Operations EMEA and LATAM, Bayer

Brian O'Dwyer, President, Global Clinical Development, IQVIA

Siân Ratcliffe, PhD, SVP, Head of Quantitative Sciences & Development Operations, Biogen

Jennifer Sheller, MPH, SVP, Head of Global Clinical Trial Operations, Global Clinical Development, Merck & Co., Inc.

Michael Young, Co-CEO, Lindus Health

9:10AM - 9:25AM

Skill-based Resource Flow Unleashes the Potential of Clinical Operations

Bernhard Glombitza, PhD, VP, Clinical Customer Engagement and Operations EMEA and LATAM, Bayer

9:25AM - 9:55AM

Reversing the Trend of Increasing Protocol Complexity

Siân Ratcliffe, PhD, SVP, Head of Quantitative Sciences & Development Operations, Biogen

Elspeth Carnan, PhD, VP, Head of Trial Delivery Support, BMS

Kenneth Getz, MBA, Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

Jill Kearney, MBA, VP, Head of Clinical Trial Management, Genmab

Liz Thompson, Global Development Leader, Senior Clinical Development Scientist, Roche

9:55AM - 10:15AM

BeOne’s Clinical Operations and Development Journey: From Vision to Scalable Architecture

Melika Davis, SVP, Global Head, Clinical Operations, BeOne Medicines

Showing Events in 1 Track from 10:15am to 10:55am

Networking Break

10:15AM - 10:55AM

Networking Break

Showing Events in 1 Track from 10:55am to 11:55am

3 Track Choices: Morning Zeitgeist Track Choices

10:55AM - 11:55AM

Morning Zeitgeist Track Choices

Showing Events in 3 Tracks from 11:00am to 11:55am

Zeitgeist Track A. Site Engagement Strategy and Accelerating Oncology Clinical Trials

Track Chair:

Jenn Curry, Head, Patient Engagement Capabilities, Biogen

11:00AM - 11:30AM

Delivering Practical Innovations that Sites Want

Martin Hodosi, Partner, Kearney

Terttu Haring, MD, Global Head, Engagement Strategy, Johnson & Johnson Innovative Medicine

Mark Scullion, CEO, Atlas Clinical Research

Katherine Senter, MPH, CCRP, Assistant Director, Cancer Clinical Research Operations, Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University

Mark Travers, PhD, MBA, Former VP, Head Global Clinical Trial Operations, Regions and Regional Operations, Merck & Co., Inc.

11:30AM - 11:55AM

Expanding Access and Accelerating Oncology Clinical Trials

Nick Slack, MBE, Chairman and CEO, The START Center for Cancer Research

Jim Eamma, MSc, Executive Director, Project Management Oncology, Worldwide Clinical Trials

Kristin Herman, MBA, Executive Director, Clinical Trials Office, Sidney Kimmel Comprehensive Cancer Center at Jefferson

Bari Kowal, SVP and Head, Development Operations, Portfolio Management and Biostatistics Data Management, Regeneron

Zeitgeist Track B. ROI of GenAI and Agentic AI’s Potential Impact

Track Chair:

Yusuf Ghadiali, Executive Director, Global Clinical Operations & Planning, Daiichi Sankyo

11:00AM - 11:30AM

Generative AI: Aligning Resources with ROI

Bari Kowal, SVP and Head, Development Operations, Portfolio Management and Biostatistics Data Management, Regeneron

Dave Apfel, MBA, Head, External Innovation, R&D Data Science and Digital Health, Johnson & Johnson

Faisal Khan, PhD, Corporate Vice President, AI and Analytics, Novo Nordisk

Subha Madhavan, PhD, VP, Head of AI/ML, Quantitative and Digital Sciences, R&D, Pfizer

Aziz Nazha, MD, Global Head, Incyte AI Innovations Institute, Incyte

11:30AM - 11:55AM

How Agentic AI Can Revolutionize Clinical Trials Operations

Angela DeLuca, MBA, PMP, Associate Vice President, Head of Global Study Operations, Amgen

Syed Waseem Haider, PhD, Head of Business, IT Partnership for AI, Merck & Co., Inc.

Youssef Idelcaid, MBA, Head of AI Research Center [ARC], Drug Development, Gilead Sciences

Henry Wei, MD, Head of Development Innovation, Regeneron Pharmaceuticals Inc

Demetris Zambas, VP, Global Head of Data Monitoring and Management, Pfizer

Zeitgeist Track C. EHR2SPONSOR Adoption Success and Pharma 2.0 Talent Development

Track Chair:

Hassan Kadhim, Head of Business Engagement, Clinical Operations and Clinical Development, Vertex Pharmaceuticals

11:00AM - 11:30AM

From Spark to Global Impact: The eSource Revolution in Pharma

Amy Cramer, MMCi, BSN, Director, Data Acquisitions, IDAR, Data Management and Central Monitoring, Johnson & Johnson Innovative Medicine

Kristin Herman, MBA, Executive Director, Clinical Trials Office, Sidney Kimmel Comprehensive Cancer Center at Jefferson

Joe Lengfellner, Senior Director, CR Informatics and Technology, Clincial Research Administration, Memorial Sloan Kettering Cancer Center

Michele Sample, VP, Late Development Oncology Clinical Operations, AstraZeneca

11:30AM - 11:55AM

Zeitgeist Fireside: Pharma Talent Management 2.0: Accelerating Skills Readiness as Technology Innovation Disrupts Drug Development

Christine Vaccola, Global Development Talent Leader, Sanofi

Moderated with:

Dennis Salotti, MS, MBA, Executive Director & Head, Clinical Outsourcing & Innovation, Jazz Pharmaceuticals

Showing Events in 1 Track from 12:00pm to 12:15pm

Interactive Session

12:00PM - 12:15PM

Industry Veteran Fireside Chat on "Real" Partnering with Sites

Kenneth Getz, MBA, Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

Daniel Perlman, Chief Executive Officer, Transformative Pharmaceutical Solutions

Showing Events in 1 Track from 12:15pm to 01:00pm

Today Show at DPHARM

12:15PM - 1:00PM

Today Show at DPHARM

Today Show Host:

Taras Carpiac, MBA, Executive Director, Innovation, Global Development Operations, Amgen

Sean Connolly, Chief Product & Technology Officer, Evinova

Diana Cucos, PhD, President, FSP 360, Syneos Health

Mike Eckrote, SVP, Strategic Solutions, Advarra

Mark Travers, PhD, MBA, Former VP, Head Global Clinical Trial Operations, Regions and Regional Operations, Merck & Co., Inc.

Showing Events in 1 Track from 01:00pm to 01:55pm

Networking Luncheon and Facilitated Roundtables

1:00PM - 1:55PM

Networking Luncheon and Facilitated Roundtables

Showing 3 of 6 Tracks

from 01:05pm to 01:55pm

Roundtable A

Leveraging Patient and Site Insights to Influence Trial Design and Optimize Patient Experience

Christie Fry, Director, Patient-Centric Trial Design, AbbVie

Levi Walrath, Clinical Strategy Lead for Digital Endpoints, Sanofi

Roundtable B

Rethinking Your Buy Vs Build Strategy

William Illis, Global Head, Collaboration and Technology Strategy, Novartis

Chris Velas, VP, Head of Digital Development, Genmab

Roundtable C

Using Data to Optimize Clinical Trial Protocols and Accelerate Patient Recruitment

Sachin Desai, Associate Director, Clinical Sciences, Novartis

Biswajit Kumar, Director, Programming and Data Operations, Novartis

Roundtable D

Breaking the Bottlenecks: Site Readiness, Contracting, and IRB Approval in Rare Disease Trials

Jen Heckman, MBA, Head of Development Operations Program Leadership, Genmab

Mitchell Katz, PhD, SVP, Global Clinical Operations, Kyowa Kirin

Roundtable E

How to Recognize and Address Bias in AI Driven Clinical Trials

Syed Waseem Haider, PhD, Head of Business, IT Partnership for AI, Merck & Co., Inc.

Anisha Suri, PhD, Associate Director, Data Science, Gilead Sciences

Roundtable F

From Patient-Centric to Human-Centric to Accelerate Building Trust and Improve Access in Healthcare

Rosa M. Colon-Kolacko, PhD, MBA, CDM, SHRM-SCP, President and Founder, Global Equity Learning and Tufts University Adjunct Professor

Patrick Gee Sr, PhD, JLC, Patient Advocate, Founder & Chief Executive Hope Dealer, iAdvocate, Inc

Barry Nelson, Patient Advocate, Lived-Experienced Expert

Showing Events in 1 Track from 02:00pm to 05:00pm

Afternoon Track Choices

2:00PM - 5:00PM

Afternoon Track Choices

Showing 3 of 4 Tracks

from 02:00pm to 05:00pm

Track A: Representation in Clinical Trials, Community Site Enrollment, Site Network Value, EHR to EDC Wins, Trial Activation Strategies

Track Chair:

Kissondra Morris, MS, MBA, Associate Director, PRC Lead, BMS

2:00PM - 2:30PM

Ensuring Patient Representation and Access in Clinical Trials

Stacey Bledsoe, RN, MSN, Head of Global Clinical Patient Engagement and Inclusion, Gilead Sciences, Inc

Racquel Bruton, MBA, Associate Director, CTD Portfolio Lead, Biogen

Michelle Chawla, PharmD, Clinical Trial Diversity Program Lead, Associate Director, Global Clinical Trial Operations, Merck

Natalie Monegro, Director, Clinical Research Equity, Novo Nordisk

2:30PM - 3:00PM

Scaling EHR-to-EDC with Site, Sponsor, and Technology

Lew Klein, Senior Director - R&D IT Capability Lead, AstraZeneca

Joe Lengfellner, Senior Director, CR Informatics and Technology, Clincial Research Administration, Memorial Sloan Kettering Cancer Center

Richard Yeatman, COO and Co-Founder, IgniteData

3:00PM - 3:25PM

Strategies to Leverage Community Networks and Amplify Oncology Patient Enrollment

Tracy Vanderslice, MSc, VP and Head, Clinical Operations Oncology, Gilead Sciences, Inc.

Therese Menear, VP, Operational Excellence, Exelixis

Marcella Schankweiler, JD, LLM, CEO, For Pete's Sake Cancer Respite Foundation

3:25PM - 4:00PM

Site Networks: Shifting from Transactional Execution to Long-Term Value

Adam Kinsey, Associate VP, Clinical Operations, Regional Head North America, Merck

Faith Gabel, Head of Project Management, Accellacare Site Network

Suvi Gross, CCRC, CEO & Co-founder, Monroe Biomedical Research

Carlos Orantes, CEO, Alcanza Clinical

Mark Scullion, CEO, Atlas Clinical Research

4:00PM - 4:35PM

Novel Approaches to Accelerate Trial Activation Timelines

Brian Mitchell, US Director of Development Operations & Acting US Regional Head Global Study Operations, Amgen

Kate Boneck, Clinical Research Director, Oncology, Merck

Elspeth Carnan, PhD, VP, Head of Trial Delivery Support, BMS

Patty Leuchten, Founder and CEO, Diligent Pharma

Andrew Vigario, MA, Senior Clinical Country & Site Lead, Biogen

4:35PM - 5:00PM

Expanding Patient Access with a Community Sites Model

Mimi Fenton, PhD, MPH, Chief Executive Officer, Cedar Health Research

Kendra Taylor, PhD, Director, Clinical Trial Capability Advancement, Pfizer

Track B: Digital Transformation, End-to-End Solutions, Global Tokenization, Regulatory Hurdles to Digital Endpoints

Track Chair:

Carrie Northcott, PhD, Head of Digital Medicine, Clinical Technologies and Biobanking, Pfizer Inc.

2:00PM - 2:45PM

Advancing Digital Transformation

Moderators:

Adama Ibrahim, MBA, Former VP Digital Transformation, R&ED, Novo Nordisk

Isaac R Rodriguez-Chavez, PhD, MHS, MS, Principal Independent Consultant & Co-chair, 4Biosolutions Consulting/IEEE-SA-DCT/DHT Program

Rinol Alaj, MS, MPH, MBA, Head of Digital Health Technologies, Regeneron

Michelle Crouthamel, PhD, Head, Digital Science, AbbVie

Victoria Gamerman, PhD, Global Head of Digital Transformation, Clinical Development Operations, Boehringer Ingelheim

Carrie Northcott, PhD, Head of Digital Medicine, Clinical Technologies and Biobanking, Pfizer Inc.

2:45PM - 3:10PM

End-to-End Tech Solutions: Bridging Planning and Delivery at Moderna

Sergey Krymgold, MS, Executive Director, Development Systems and Data Strategy, Moderna

3:10PM - 3:45PM

Leveraging Tokenization Globally: Opportunities and Challenges

Tom Dougherty, Data Science and AI Innovative Partnership Lead, Novo Nordisk

Carissa Dukes, MPH, Director, Global Epidemiology & RWE, Boehringer Ingelheim

Biswajit Kumar, Director, Programming and Data Operations, Novartis

Kevin Rutty, Director, Group Lead, Clinical Data & Information Sciences, Pfizer

3:45PM - 4:25PM

Addressing Barriers to Regulatory Acceptance of Novel Digital Measures

Jacqueline Thong, MBA, General Manager, US, DEEP Measures

Michelle Crouthamel, PhD, Head, Digital Science, AbbVie

Carrie Northcott, PhD, Head of Digital Medicine, Clinical Technologies and Biobanking, Pfizer Inc.

Andrew Pearlmutter, Associate Director, Patient Centered Outcomes Science, BioMarin Pharmaceuticals, Inc.

4:25PM - 4:50PM

Integrating HCP/HCO Data with RWD to Bring Clinical Trials Closer to Patients

Preeti Chawla, Data Domain Owner, Boehringer Ingelheim

Track C. Protocol Digitization, Patient Matching, In-life Trial Enrollment Reforecasting, AI Powered Audit Trails, Polygenic Risk Scores

Track Chair:

Rucha Shah, Lived-experience Expert, and Assistant Clinical Research Project Manager, ECOG-ACRIN Cancer Research Group

2:00PM - 2:25PM

Protocol Digitization to Accelerate Development Timelines

William Illis, Global Head, Collaboration and Technology Strategy, Novartis

Neha Begum, Associate Director, Drug Development IT, BMS

Vivian Combs, MS, Director, Scientific Communications, Diabetes Business Unit, Eli Lilly and Company

2:25PM - 3:05PM

Clinical Trial Patient Matching in 2025 - State of the Union

Sean Lynch, Innovative Capabilities Head, Innovative Trial Operations, Novartis

Michaela Bertram, Clinical Cancer Research Manager, Avera Cancer Institute

Benjamin Jackson, VP Commercial, SanoGenetics

Chelsea Osterman, MD, Senior Medical Director, Tempus

Alyssa Tarantino, Innovation Lead, BMS

Adrienne Walstrum, MSc, Senior Director, Global Trial Optimization, Merck

3:05PM - 3:15PM

The Impact of Optimizing Regulatory Drafting with AI

Lindsay Mateo, MBA, Chief Commercial Officer, Weave Bio

3:15PM - 3:35PM

Leveraging In-life Trial Enrollment Reforecasting Methods for Operational Decision-making

Sara Kohnke, PhD, Senior Data Scientist, Vertex Pharmaceuticals

3:35PM - 3:55PM

Digitizing Public Clinical Trial Protocols for Data-Driven Trial Design

Kelly Hoang, PhD, Associate Director, Data Scientist, Gilead Sciences

3:55PM - 4:15PM

Deploying AI to Streamline Audit Trail Reviews

Alex Crawford, Associate Director, Clinical Innovation, Jazz Pharmaceuticals

4:15PM - 4:40PM

Integrating Patient Insights Early on to Increase Global Patient Enrollment

Anna Osinski, Associate Director, Patient Centricity and Engagment Development Unit Lead, Biogen

Track D: Innovating with Less for Biotechs: Resourceful Approaches to Deploying Clinical Trial Innovation

Track Chair:

Murray Abramson, MD, MPH, Chief Development Officer, Ascidian Therapeutics

2:00PM - 2:05PM

Co-Chair Opening Remarks

Murray Abramson, MD, MPH, Chief Development Officer, Ascidian Therapeutics

2:05PM - 2:45PM

Adapting Operating Models to Meet the Urgent Need for Speed in Clinical Development

Tara Aldoory, VP, Head of Clinical Trial Delivery, Biogen

Yusuf Ghadiali, Executive Director, Global Clinical Operations & Planning, Daiichi Sankyo

Mitchell Katz, PhD, SVP, Global Clinical Operations, Kyowa Kirin

Jill Kearney, MBA, VP, Head of Clinical Trial Management, Genmab

Marie Rosenfeld, SVP, Clinical Operations and Data Management, Entrada Therapuetics

2:45PM - 3:25PM

Setting your Strategy for Adopting AI and Emerging Tech Solutions

Craig Serra, MBA, Executive Data Management and Clinical Systems Leader, Independent Consultant

Alex Crawford, Associate Director, Clinical Innovation, Jazz Pharmaceuticals

Paulius Ojeras, Head of Clinical Operations, Perceive Biotherapeutics

Chris Velas, VP, Head of Digital Development, Genmab

3:25PM - 3:55PM

Preparing for Tomorrow’s Skill Set for Clinical Operations

Alice Donnelly, SVP, Clinical Operations, Alnylam

Mary Brantner, Senior Director, Clinical Program Optimization and Innovation, Insmed Incorporated

Jen Heckman, MBA, Head of Development Operations Program Leadership, Genmab

Charlie Semenchuk, Sr Director - Head of GCDO Business & Technology Capabilities, Jazz Pharmaceuticals

3:55PM - 4:25PM

Effective Service Provider Partnership Strategies and Governance on a Budget

Murray Abramson, MD, MPH, Chief Development Officer, Ascidian Therapeutics

Jennifer Burg, SVP, Clinical Development Operations, Axonis Therapeutics

Melanie Goodwin, Director, Clinical Outsourcing, Immunocore

Erin Jacques, Associate Director, Clinical Vendor Alliance Management, Insmed

Amanda Moore, VP, Program Leadership and Clinical Operations, Abeona Therapeutics

Kort Schickfus, Senior Vice President, Chief Business Officer, Research & Development Solutions, IQVIA

4:25PM - 4:55PM

Resourceful Patient Recruitment Strategies for Rare Disease

Mitchell Katz, PhD, SVP, Global Clinical Operations, Kyowa Kirin

Kristin Blouch, MSc Precision Medicine, Senior Director, Patient Recruitment & Retention Strategy, Exelixis

Jenn Curry, Head, Patient Engagement Capabilities, Biogen

Amanda Decoker, Senior Director, Patient Recruitment and Retention, Takeda

Maureen Quinn, MBA, Manager, Patient Recruitment and Retention, Moderna

4:55PM - 5:00PM

Closing Remarks